Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lewis B Silverman

Showing results (71-80 of 188) with videos related to

Pageof 19
Sort By:
Leukemia|January 4, 2024
Treatment completion, asparaginase completion, and oncologic outcomes among children, adolescents and young adults with acute lymphoblastic leukemia treated with DFCI Consortium ProtocolsYannis K Valtis, Yael Flamand, Shai Shimony, et al.
The Pharmacogenomics Journal|December 29, 2017
Influence of BCL2L11 polymorphism on osteonecrosis during treatment of childhood acute lymphoblastic leukemiaMaria Plesa, Vincent Gagné, Sanja Glisovic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 8, 2014
Polymorphisms of asparaginase pathway and asparaginase-related complications in children with acute lymphoblastic leukemiaMohsen Ben Tanfous, Bahram Sharif-Askari, Francesco Ceppi, et al.
Experimental Hematology|February 26, 2005
Failure to define window of time for autologous tumor vaccination in patients with newly diagnosed or relapsed acute lymphoblastic leukemiaW Nicholas Haining, Angelo A Cardoso, Heather L Keczkemethy, et al.
Cancer Cell|November 4, 2008
H3K79 methylation profiles define murine and human MLL-AF4 leukemiasAndrei V Krivtsov, Zhaohui Feng, Madeleine E Lemieux, et al.
American Journal of Hematology|September 18, 2007
Aggressive Langerhans cell histiocytosis following T-ALL: clonally related neoplasms with persistent expression of constitutively active NOTCH1Scott J Rodig, Ethan G Payne, Barbara A Degar, et al.
Pediatric Blood & Cancer|December 9, 2024
Feasibility of Utilizing a Brief Neurocognitive Battery in 3-Year-Old Patients During Treatment for Acute Lymphoblastic LeukemiaSameera Ramjan, Peter D Cole, Melanie Blair-Thies, et al.
Pediatric Blood & Cancer|July 17, 2023
Impairment of health-related quality of life for children with acute lymphoblastic leukemia over the first year of therapy: A report from the DFCI ALL ConsortiumJennifer J G Welch, Yael Flamand, Kristen E Stevenson, et al.
Haematologica|September 17, 2013
Impact of promoter polymorphisms in key regulators of the intrinsic apoptosis pathway on the outcome of childhood acute lymphoblastic leukemiaRocio Sanchez, Janick St-Cyr, Marie-Eve Lalonde, et al.
Pediatric Blood & Cancer|January 10, 2026
Trajectory of Neurocognitive Functioning in Children Treated for Acute Lymphoblastic Leukemia (ALL): Dana-Farber Cancer Institute ALL Consortium Study 16-001Alexandra Thrope, Sameera Ramjan, Charlie White, et al.
Pageof 19

Showing results (71-80 of 188) with videos related to

Sort By:
Pageof 19
Leukemia|January 4, 2024
Treatment completion, asparaginase completion, and oncologic outcomes among children, adolescents and young adults with acute lymphoblastic leukemia treated with DFCI Consortium ProtocolsYannis K Valtis, Yael Flamand, Shai Shimony, et al.
The Pharmacogenomics Journal|December 29, 2017
Influence of BCL2L11 polymorphism on osteonecrosis during treatment of childhood acute lymphoblastic leukemiaMaria Plesa, Vincent Gagné, Sanja Glisovic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 8, 2014
Polymorphisms of asparaginase pathway and asparaginase-related complications in children with acute lymphoblastic leukemiaMohsen Ben Tanfous, Bahram Sharif-Askari, Francesco Ceppi, et al.
Experimental Hematology|February 26, 2005
Failure to define window of time for autologous tumor vaccination in patients with newly diagnosed or relapsed acute lymphoblastic leukemiaW Nicholas Haining, Angelo A Cardoso, Heather L Keczkemethy, et al.
Cancer Cell|November 4, 2008
H3K79 methylation profiles define murine and human MLL-AF4 leukemiasAndrei V Krivtsov, Zhaohui Feng, Madeleine E Lemieux, et al.
American Journal of Hematology|September 18, 2007
Aggressive Langerhans cell histiocytosis following T-ALL: clonally related neoplasms with persistent expression of constitutively active NOTCH1Scott J Rodig, Ethan G Payne, Barbara A Degar, et al.
Pediatric Blood & Cancer|December 9, 2024
Feasibility of Utilizing a Brief Neurocognitive Battery in 3-Year-Old Patients During Treatment for Acute Lymphoblastic LeukemiaSameera Ramjan, Peter D Cole, Melanie Blair-Thies, et al.
Pediatric Blood & Cancer|July 17, 2023
Impairment of health-related quality of life for children with acute lymphoblastic leukemia over the first year of therapy: A report from the DFCI ALL ConsortiumJennifer J G Welch, Yael Flamand, Kristen E Stevenson, et al.
Haematologica|September 17, 2013
Impact of promoter polymorphisms in key regulators of the intrinsic apoptosis pathway on the outcome of childhood acute lymphoblastic leukemiaRocio Sanchez, Janick St-Cyr, Marie-Eve Lalonde, et al.
Pediatric Blood & Cancer|January 10, 2026
Trajectory of Neurocognitive Functioning in Children Treated for Acute Lymphoblastic Leukemia (ALL): Dana-Farber Cancer Institute ALL Consortium Study 16-001Alexandra Thrope, Sameera Ramjan, Charlie White, et al.
Pageof 19